Language: Deutsch

Gilead Sciences GesmbH

Wagramer Strasse 19 
1220 Wien
Austria

Phone: 43 (0) 1260 83 0
Fax: 43 (0)1 260 83 99

Drug Safety/Adverse Event Reporting

Phone: +43 (0) 1 260 83-0
Fax: +43 (0) 1 260 83-99
E-Mail: AustriaSafetyMailbox@gilead.com

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Gilead's Vienna office opened in 2007. It is responsible for Gilead's commercial operations in Austria. The team is committed to offering and maintaining high-quality service to the medical community and is focused on the distribution of our products throughout the country.

Transparency Reporting
In line with local Transparency Reporting requirements, Gilead is disclosing its interactions with HealthCare Professionals and HealthCare Organisations in Austria in the following report, supported by a Methodological Note. Enquiries about the report should be directed to: http://www.gilead.com/news/media-inquiries.

Gilead Sciences Austria EFPIA Report 2017
Gilead Sciences Austria EFPIA Methodological Note 2017
Gilead Sciences Austria EFPIA Report 2016
Gilead Sciences Austria EFPIA Methodological Note 2016
Gilead Sciences Austria EFPIA Report 2015
Gilead Sciences Austria EFPIA Methodological Note 2015

Concerning lobbying-activities Gilead Austria fully adheres to all applicable laws and rules, including, but not limited to the ”Lobbying-und Interessenvertretungs-Transparenz-Gesetz – LobbyG”. Gilead Austria adopted the “Pharmig Lobbying-Verhaltenskodex”, available under http://pharmig.at/DE/Publikationen/Lobbying-Verhaltenskodex/Lobbying-Verhaltenskodex.aspx.

Support of Patient Organizations and NGOs

Gilead provided support to the following patient organizations in 2017. The information is correct at the time of writing June 2018. The information is subject to change and will be updated accordingly. For a listing of previous years’ support, click here.

  • Grant Recipient
    Description of Activity
    Amount Funded €
  • Aids Hilfe Kärnten
    Sponsorship of HIV Update: Diagnosis and Therapy
    2,500.00
  • Aids Hilfe Kärnten
    Sponsorship of Outpatient HIV & HCV testing at Clubbings 2017
    3,000.00
  • Aids Hilfe Kärnten
    Sponsorship of European Test Week 2017
    2,000.00
  • Aids Hilfe Wien
    Sponsorship of on-site HIV test consulting for MSM
    377.00
  • Aids Hilfe Wien
    Sponsorship of Vienna AIDS Day
    1,250.00
  • Aids Hilfe Wien
    Sponsorship of World Aids Day
    5,902.00
  • Aidshilfe Salzburg
    Sponsorship of website
    2,000.00
  • AmberMed Verein
    Grant funding to support the therapy of uninsured patients with chronic hepatitis B
    7,500.00
  • BipsoMed Verein
    Grant funding to support the project: Adherence Nurse
    12,943.00
  • Hepatitis Hilfe Österreich
    Sponsorship of Hepatitis Week 2017: Press Conference on World Hepatitis Day 2017
    5,000.00
  • Hepatitis Hilfe Österreich
    Sponsorship of European Test Week 2017
    4,500.00
  • Hepatitis Hilfe Österreich
    Sponsorship of Come-In Talks December 2016
    3,900.00
  • Hepatitis Hilfe Österreich
    Sponsorship of Journalistenworkshop, Vienna Competence Center
    750.00
  • Hepatitis Hilfe Österreich
    Sponsorship of Pilotprojekt "HepC Eradikation: es ist möglich!”, 7. Gipfelgespräch im Stift Seitenstetten im Rahmen des 2. Praevenire Gesundheitsforums
    400.00
  • Hepatitis Hilfe Österreich
    Grant funding to support Hepatitis projects
    15,000.00
  • Jugend gegen Aids
    Sponsorship of Various projects for World AIDS Day 2017
    13,000.00
  • LIFE+ Verein zur direkten Unterstützung von HIV-Positiven und an AIDS erkrankten Menschen
    Sponsorship of Advertisement and cover of World AIDS Day
    17,697.00
  • PROJEKT INFORMATION E.V.
    Sponsorship of Project Information Subscription 2017
    600.00
Language: Deutsch


This page is intended for visitors outside of the United States.